Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
The peptide does not appear to significantly alter IGF-1 levels, pose a risk for cancer progression, or induce insulin resistance
Wide therapeutic window: Animal studies showed activity even at ultra-low doses (10 ng/kg), suggesting BPC-157 is active across a broad dose range (Krivic et al., 2006)
This outperformance of an established clinical therapy suggests significant potential for diabetic wound applications
The scheduling must be set on the first appointment
Supply Ability 5000 Per Month 1000000 Per Month Main Domestic Market All India Manipur, Chandigarh, Himachal Pradesh, Andaman and Nicobar Islands, Pondicherry, Uttarakhand, Daman and Diu, Dadra and Nagar Haveli, Lakshadweep, South India, North India, East India, West India, Assam, Arunachal Pradesh, Goa, Haryana, Jammu and Kashmir, Jharkhand, Karnataka, Madhya Pradesh, Maharashtra, Mizoram, Meghalaya, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura, West Bengal, Nagaland, Punjab, Kerala, Delhi, Gujarat, Bihar, Andhra Pradesh, Central India, Odisha, Chhattisgarh, Uttar Pradesh, All India People Also Viewed
US$ 26.16
US$ 25.90
US$ 29.80
US$ 21.65
US$ 20.44
